English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduA CDC insider’s recollections from 60 years ago, plus circumstantial evidence, indicate the Tuskegee syphilis study was not kept secret from some top Black physicians as it progressed.
Tag: Medical Ethics
Study reveals vital role of supportive managers to minimize physical restraint use in care homes
A new Cochrane review finds that the use of physical restraints on care home residents can be reduced without increasing the risk of falls, when frontline care staff are empowered by supportive managers.
Mount Sinai Fellow Salman E. Qasim, PhD, Awarded Prestigious Essay Prize From Lasker Foundation
The Lasker Foundation announced today that Salman E. Qasim, PhD, a postdoctoral fellow at the Icahn School of Medicine at Mount Sinai, is among five winners of its 10th annual Lasker Essay Contest.
AI nursing ethics: viability of robots and artificial intelligence in nursing practice
The recent progress in the field of robotics and artificial intelligence (AI) promises a future where these technologies would play a more prominent role in society. Current developments, such as the introduction of autonomous vehicles, the ability to generate original artwork, and the creation of chatbots capable of engaging in human-like conversations, highlight the immense possibilities held by these technologies.
GPT-3 informs and disinforms us better
A recent study conducted by researchers at the University of Zurich delved into the capabilities of AI models, specifically focusing on OpenAI’s GPT-3, to determine their potential risks and benefits in generating and disseminating (dis)information.
During the pandemic, hospital transfers were complex and distressing
A U-M study examined the factors that went into decision-making around hospital transfers during the pandemic—and the moral distress that often resulted from it.
Three Penn Medicine Faculty Members Named Hastings Center Fellows
Three faculty from the Perelman School of Medicine at the University of Pennsylvania have been named 2023 Hastings Center Fellows. Emily Largent, PhD, RN, Peter Reese, MD, PhD, and Dominic Sisti, PhD, are among 12 new Fellows joining an elected group of over 200.
Team including CWRU law and medicine faculty awarded of $1.6 million grant to study ethics of ‘nudging’ people into research participation
CLEVELAND—In the late-1950s, market researchers inserted subliminal messages into movies, encouraging the audience to “eat popcorn” and “drink Coca-Cola.” It didn’t take long for the Federal Communications Commission and U.S. courts to ban subliminal advertising—messages not consciously perceived by the…
Lessons from the Tuskegee Experiment, 50 Years After Unethical Study Uncovered
This year marks 50 years since it came to light that the nation’s leading public health agency, the Public Health Service, conceived an unethical “research study” – the Tuskegee Experiment – that lasted for 40 years. The participants? Black men in a rural community in the South who existed in a state of quasi-slavery, making them extremely vulnerable and the agency’s treatment of them that much more sickening.
Safety board members describe stringent oversight of U.S. COVID-19 vaccine trials
In a new report published in the Journal of Infectious Diseases, the 11-member Data and Safety Monitoring Board (DSMB) that is overseeing the federally funded COVID-19 vaccine trials outlines its mission, procedures, and the challenges that it faced in monitoring…
University Hospitals named for the ninth time as one of the World’s Most Ethical Companies by Ethisphere
Announcement that University Hospitals (UH) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of 2021 World’s Most Ethical Companies. UH is one of only seven honorees in the health care providers’ category, in 2021.
Researchers Propose Transformative Framework for Delivering Virtual Care
In “Ensuring Quality in the Era of Virtual Care,” published this month in the Journal of the American Medical Association (JAMA), the authors discuss the growing popularity of virtual care in an environment that has had limited discussions about its quality and trade-offs.
How should hospitals ask patients for donations?
A new study looks for the first time at patients’ views of hospital fundraising, including legally allowable practices that encourage physicians to work with their hospital’s fundraising professionals.
As hospitals walk the tightrope of patient data-sharing, one system offers a new balance
Every major medical center in America sits on a gold mine of patient data that could be worth millions of dollars to companies that could use it to develop new treatments and technologies. A new framework could help them do so more responsibly, going beyond the minimum legal requirements and respecting patients by giving them more say in how their individual data may be used.
Renowned Bioethicist Co-Chairs Effort to Help Cities Safely Reopen Sports and Recreation Amidst Pandemic
Arthur L. Caplan, PhD, the Drs. William F and Virginia Connolly Mitty Professor of Bioethics at NYU Langone Health and the founding director of the Division of Medical Ethics in the Department of Population Health, is co-chairing a newly-created United States Conference of Mayors (USCM) Advisory Panel on Sports, Recreation, and Health.
The Ethics of COVID-19
As some governors are moving to ease COVID-19 restrictions, the virus is causing patients, medical professionals and community members to face unprecedented ethical dilemmas in their day-to-day lives and careers. “As social animals who live in community, this pandemic has made us unable to ignore the issue, and significance of, social obligation,” says Stuart Finder, PhD, MA, director of the Center for Healthcare Ethics at Cedars-Sinai.
New in the Hastings Center Report: A call to confront mistrust in the US health care system
“For those who have faced exploitation and discrimination at the hands of physicians, the medical profession, and medical institutions, trust is a tall order and, in many cases, would be naïve,” writes Laura Specker Sullivan in “Trust, Risk, and Race in American Medicine.”
Direct-to-Consumer Fertility Tests Confuse and Mislead Consumers, Penn Study Shows
Direct-to-consumer hormone-based “fertility testing” for women is viewed by consumers as both an alternative, empowering tool for family planning, and a confusing and misleading one, according to the results of a new study from Penn Medicine. Findings from the small, first-of-its-kind ethnographic study reinforce the need for consumer education around the purpose and accuracy of the tests, which have seen increasing interest in recent years due to the low cost and widespread availability. The study was published in the journal of Social Science and Medicine.
Human rights activist awarded MacLean Center ethics prize
Physician and human rights activist Steven Miles, MD, Professor Emeritus of Medicine and Bioethics at the University of Minnesota, won the 2019 MacLean Center Prize in Clinical Ethics and Health Outcomes.
How Oncologists Can Ethically Navigate the “Right-to-Try” Drug Law
The 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs that have not yet been approved by the Food and Drug Administration (FDA). Many in the oncology community say Right to Try strips away important regulatory protections and view the move as a risky step bound to create ethical dilemmas for physicians whose goal is to guide patients toward safe and appropriate treatment decisions. Oncology is one field at the forefront of requests for unapproved drugs. An interdisciplinary team of bioethicists, oncologists, and lawyers from Penn Medicine and other institutions penned a commentary published online this week in the Journal of Clinical Oncology to offer recommendations to help oncologists navigate this new “Right to Try” world, while maintaining their ethical obligations to patients.
Study finds lack of racial diversity in cancer drug clinical trials
New research published this week in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. It raises concerns about the effectiveness of cancer drugs in some patients, especially since genetic differences may affect how a patient responds to a drug.